Exploring the effects of probiotics on olanzapine-induced metabolic syndrome through the gut microbiota
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Exploring the effects of probiotics on olanzapine-induced metabolic syndrome through the gut microbiota ; volume:16 ; number:1 ; day:21 ; month:12 ; year:2024 ; pages:1-23 ; date:12.2024
Gut pathogens ; 16, Heft 1 (21.12.2024), 1-23, 12.2024
- Urheber
-
Mushraf, Syed
Chawla, Kiran
Fayaz, Shaik Mohammed Abdul
Mathew, Aranjani Jesil
Reddy, Gayam Prasanna Kumar
Kappettu Gadahad, Mohandas Rao
Shenoy, Padmaja A.
Devi, Vasudha
Adiga, Shalini
Nayak, Veena
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13099-024-00664-2
- URN
-
urn:nbn:de:101:1-2503022117384.579339430234
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mushraf, Syed
- Chawla, Kiran
- Fayaz, Shaik Mohammed Abdul
- Mathew, Aranjani Jesil
- Reddy, Gayam Prasanna Kumar
- Kappettu Gadahad, Mohandas Rao
- Shenoy, Padmaja A.
- Devi, Vasudha
- Adiga, Shalini
- Nayak, Veena
- SpringerLink (Online service)
Ähnliche Objekte (12)
Probiotics and microbiota composition
Gut microbiota, probiotics and diabetes
Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics
Targeting the microbiome: from probiotics to fecal microbiota transplantation
Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry
Olanzapine: The Game-Changer “Antiemetic”
Intestinal microbiota in human health and disease: the impact of probiotics
Microbiota and neurologic diseases: potential effects of probiotics
The intestinal microbiota in metabolic disease
Zebrafish shares common metabolic pathways with mammalian olanzapine-induced obesity
Probiotics in human gut microbiota can degrade host glycosaminoglycans
Olanzapine-induced mania
Probiotics and microbiota composition
Gut microbiota, probiotics and diabetes
Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics
Targeting the microbiome: from probiotics to fecal microbiota transplantation
Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry
Olanzapine: The Game-Changer “Antiemetic”
Intestinal microbiota in human health and disease: the impact of probiotics
Microbiota and neurologic diseases: potential effects of probiotics
The intestinal microbiota in metabolic disease
Zebrafish shares common metabolic pathways with mammalian olanzapine-induced obesity
Probiotics in human gut microbiota can degrade host glycosaminoglycans
Olanzapine-induced mania
Probiotics and microbiota composition
Gut microbiota, probiotics and diabetes
Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics
Targeting the microbiome: from probiotics to fecal microbiota transplantation
Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry
Olanzapine: The Game-Changer “Antiemetic”
Intestinal microbiota in human health and disease: the impact of probiotics
Microbiota and neurologic diseases: potential effects of probiotics
The intestinal microbiota in metabolic disease
Zebrafish shares common metabolic pathways with mammalian olanzapine-induced obesity
Probiotics in human gut microbiota can degrade host glycosaminoglycans